MHRA and Swissmedic sign MoU on improving international collaboration

With around 75 agency representatives from 23 countries attending, the two-day summit is being held in Switzerland for the first time and organized by Swissmedic, the Swiss Agency for Therapeutic Products.

The objective of the annual meeting of medicinal and therapeutic products authorities is to promote information sharing and improve networking among agencies. The topics on the agenda of the 11th Summit of Heads of Medicines Regulatory Agencies in Interlaken, Switzerland, include regulatory transparency, as well as best practices in cooperation and dialogue with stakeholders.

As part of the 11th Summit of the Heads of Medicines Regulatory Agencies, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has signed a memorandum of understanding (MoU) with its Swiss counterpart, Swissmedic.